Insilico Fast-Tracks First AI-Designed TNIK Inhibitor For IPF

New Results Released In IPO Filing

 
• By Dexter Jie Yan
  
Racetrack
InSilico racing against global competitors for disease-modifying therapy for idiopathic pulmonary fibrosis. • Source: Shutterstock

More from China

More from Respiratory